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Ninjurin1 is a transmembrane protein involved in macrophage 
migration and adhesion during inflammation. It was recently reported 
that the repression of Ninjurin1 attenuated the lipopolysaccharide 
(LPS)-induced inflammatory response in macrophages; however, the 
precise mechanism by which Ninjurin1 modulates LPS-induced 
inflammation remains poorly understood. In the present study, it was 
 ii
found that the interaction between Ninjurin1 and LPS contributed to the 
LPS-induced inflammatory response. Notably, pull-down assays using 
lysates from HEK293T cells transfected with human or mouse 
Ninjurin1 and biotinylated LPS (LPS-biotin) showed that LPS directly 
bound Ninjurin1. Subsequently, LPS binding assays with various 
truncated forms of Ninjurin1 protein revealed that amino acids (aa) 81–
100 of Ninjurin1 were required for LPS binding. In addition, 
knockdown experiments using Ninj1 siRNA resulted in decreased nitric 
oxide (NO) and tumor necrosis factor-alpha (TNFα) secretion upon 
LPS treatment in Raw264.7 cells. Collectively, our results suggest that 
Ninjurin1 regulates the LPS-induced inflammatory response through its 
direct binding to LPS, thus, identifying Ninjurin1 as a putative target 
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Inflammation is a response of body against infection, tissue 
injury, or cellular stress (Medzhitov 2008). Inflammatory response is 
mainly accomplished by immune cells including macrophages, 
dendritic cells, mast cells, neutrophils, B cells, and T cells (Luster, Alon 
et al. 2005). These immune cells are rapidly delivered to the site of 
inflammation, through permeabilized blood vessels and an attraction by 
cytokines (Ley, Laudanna et al. 2007). 
Inflammation is involved with diverse pathological processes, 
including infection, diabetes, atherosclerosis, neurodegenerative 
disease, and cancer (Medzhitov 2010). In particular, inflammation plays 
a critical role in host defense system resistance to microbial infection. 
The host defense system against microorganisms includes innate and 
adaptive immunity. The innate immunity is activated immediately after 
the invasion of pathogen and prolonged hours and days, whereas the 
adaptive immunity is initiated later, about 4–7 days after infection and 
mediated by T-lymphocytes and B-lymphocyte with rearrangement of 
 ２
genes encoding antigen receptors (Netea, van der Graaf et al. 2004, 
Albiger, Dahlberg et al. 2007). The main part of the innate immune 
system relies on inflammatory activation of immune cells such as 
macrophages, polymorphonuclear leukocyte, and dendritic cells. These 
immune cells are activated through the recognizing conserved 
microbial component called pathogen-associated molecular patterns 
(PAMPs) including formylated peptides, mannans, peptidoglycans, LPS, 
lipopeptides. In the host immune cell part, pattern recognition receptors 
(PRRs) are expressed for the recognition of PAMPs. PRRs include Toll-
like receptors (TLRs), nucleotide-binding oligomerization domain 
proteins (NOD-like receptors, NLRs), mannan binding lectin (MBL), 
and C-reactive protein (CRP) (Aderem and Ulevitch 2000, Janeway 
and Medzhitov 2002, Hargreaves and Medzhitov 2005). Although the 
controlled inflammatory responses have beneficial effect in an 
eradication of pathogenic microbials, inadequate pro-inflammatory 
responses and anti-inflammatory immunosuppression trigger severe 
disease, septic shock. Therefore, the fine regulation of inflammation is 
a crucial issue and therapeutic target for infectious diseases (Annane, 




Ninjurin1 was originally identified as an upregulated protein in 
injured nerves and is comprised of two transmembrane domains (aa 
72–100 and aa 118–139), N-terminal (aa 1–71) and C-terminal (aa 140–
152) extracellular domains, and cytosolic region (aa 101–117). (Araki 
and Milbrandt 1996) (Figure 1). In addition, an 11-residue region (aa 
26-37), which located in extracellular N-terminus, was identified as 
homophilic binding domain of Ninjurin1 (Araki, Zimonjic et al. 1997). 
Ninjurin1 is expressed in diverse tissues, and various roles 
have been reported in developmental and pathological situations. Bone 
marrow-derived macrophages from Ninjurin1 knock-out (KO) mice 
decrease the basal motility and transendothelial migration (Ahn, Le et 
al. 2014), and the antibody mediated neutralization of Ninjurin1 in BV2 
macrophage cell line inhibits macrophage attachment on the endothelial 
cells (Lee, Ahn et al. 2009). Moreover, Ninjurin1 over-expression was 
observed in experimental autoimmune encephalomyelitis (EAE) in 
mice and multiple sclerosis (MS) in human, and blocking Ninjurin1 
using specific antibodies attenuates the susceptibility and migration of 
leukocyte into the inflammatory lesions of central nervous system 
 ４
(Ifergan, Kebir et al. 2011, Ahn, Le et al. 2014). Additionally, mouse 
embryonic fibroblasts (MEF) isolated from Ninjurin1 KO mice show 
that the enhanced apoptosis, cellular senescence, and radiosensitivity 
compared to the wild type (WT) in a p53-dependent manner (Cho, 
Rossi et al. 2013). Besides Ninjurin1 expression was up-regulated in 
tumors including hepatocellular carcinoma (Kim, Moon et al. 2001), 
bladder cancer (Mhawech-Fauceglia, Ali et al. 2009), and B-cell 
leukemia (Chen, Coustan-Smith et al. 2001). 
Compared to the studies of various functions of Ninjurin1, the 
underlying mechanisms are relatively remains unknown. Despite of the 
recent study that Ninjurin1 modulates TLR4-dependent activation of 
inflammatory molecules upon stimulation by LPS (Jennewein, Sowa et 
al. 2015), more studies are necessary to find how it transduces the 
signal from cell membrane to intermediate molecules. 
 ５
 
Figure 1. Diagrammatic description of Ninjurin1. 
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3. Bacterial endotoxin 
 
Bacterial infection is a major cause of inflammation and 
mediated by a variety of bacterial cell compartments (Akira 2009). LPS 
in the outer membrane is a principal pathogenic molecule in the case of 
gram-negative bacteria, whereas plasma membrane lipoprotein plays a 
similar role in mycoplasma, which lacks a cell wall and outer 
membrane (Chambaud, Wroblewski et al. 1999). Both LPS and 
lipoprotein contain lipid moieties—lipid A and a lipoylated amino-
terminal cysteinyl residue, respectively—that are responsible for 
stimulating the host immune response (Chambaud, Wroblewski et al. 
1999, Beutler and Rietschel 2003). Ag 243-5 lipoprotein, originally 
isolated from Mycoplasma arginini, but also described as the P47 
lipoprotein of M. hyorhinis, is reported to have a metastasis-promoting 
activity (Ushio, Iwaki et al. 1995, Calcutt, Kim et al. 1999). 
Interestingly, Ag 243-5 shows significant sequence homology with 
macrophage-activating lipoprotein-404 (MALP-404) from M. 
fermentans, which is known to increase cytokine production in human 
monocytes (Rosati, Pozzi et al. 1999). 
Several LPS binding molecules facilitate the biological effect 
 ７
of LPS on host cells. For instance, LPS-binding protein (LBP) binds 
aggregated LPS and then delivers monomeric LPS to CD14 (Hailman, 
Lichenstein et al. 1994). Membrane anchored protein CD14 functions 
as a critical TLR4 co-receptor, and transfers LPS to the myeloid 
differentiation factor 2 (MD2)-TLR4 complex (Wright, Ramos et al. 
1990). Finally, LPS triggers the dimerization of TLR4, which 
subsequently initiates intracellular signaling cascades (Miyake 2004, 
Jerala 2007). Besides, several other proteins are reported to bind LPS, 
including high mobility group box 1 protein (HMGB1) (Youn, Oh et al. 
2008), CXCR4 (Triantafilou, Triantafilou et al. 2001), and β2-
glycoprotein I (Agar, de Groot et al. 2011). These proteins are actively 
studied as inflammatory regulators and therapeutic candidates in 
inflammatory diseases, but the current data is not sufficient to address 
any significant applications. 
 ８
LPS from gram-negative bacteria cell wall and lipoprotein from 
mycoplasma plasma membrane (Seya and Matsumoto 2002, Cardoso, 
Macedo et al. 2006). 




The genus Cinnamomum is comprises of approximately 250 
species evergreen trees distributed all over the world. The bark of these 
trees is used not only as a popular spices but also as a traditional herbal 
medicine (Rao and Gan 2014, Nabavi, Di Lorenzo et al. 2015). 
Traditionally, plant part of Cinnamomum has been used as an 
antipyretic, antifungal, antimicrobial, anticancer, antioxidant, and anti-
inflammatory agent (Mancini-Filho, Van-Koiij et al. 1998, Tung, Chua 
et al. 2008, Baker, Chohan et al. 2013, Mustaffa, Indurkar et al. 2013). 
According to previous studies, 2-methoxycinnamaldehyde (2-MCA) is 
identified in C. cassia and C. zeylanicum, which are the most common 
species of genus Cinnamomum used as food (Lee, Lee et al. 2005, 
Gunawardena, Karunaweera et al. 2015) (Figure 3). 
2-MCA was studied in macrophages, endothelial cells, tumor 
cells, and platelet for anti-inflammatory, anti-oxidant, suppression 
osteoclastogenesis, anti-angiogenesis, and anti-aggregation activities 
(Reddy, Seo et al. 2004, Lee, Lee et al. 2005, Guo, Huo et al. 2006, 
Tsuji-Naito 2008, Kim, Koo et al. 2010, Yamakawa, Kidoya et al. 2011, 
Hwa, Jin et al. 2012, Gunawardena, Karunaweera et al. 2015) (Table 1). 
 １０
In particular, anti-inflammatory and anti-oxidant activities of 2-MCA 
were investigated in macrophages and endothelial cells. When 
Raw264.7 and J774A.1 macrophage cell line was activated by LPS, 2-
MCA exhibited IC50 for NO of 55±9 μM and 35±9 μM, respectively; 
and IC50 for TNFα of 63±9 μM and 78±16 μM , respectively 
(Gunawardena, Karunaweera et al. 2015). Moreover, the production of 
prostaglandin E2 and cyclooxygenase-2 in rat cerebral endothelial cells 
were inhibited by 2-MCA in a dose-dependent manner (Guo, Huo et al. 
2006). As underlying mechanisms, 2-MCA reduced transcriptional 
activity of NF-κB in luciferase reporter assays (Reddy, Seo et al. 2004, 
Lee, Lee et al. 2005); and translocation of Nrf2 transcription factor was 
inhibited by 2-MCA (Hwa, Jin et al. 2012). However, the previous 
investigation for macrophages was only performed in cell lines, 
Raw264.7 and J774A.1, which did not use primary macrophages. In 
addition, the effect of 2-MCA on Nrf2 are not studied in macrophages. 
Therefore, inclusive investigations for effect of 2-MCA on 








Table 1. Role of 2-MCA in various cells. 
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5. Nrf2 and ATF3 
 
Nuclear factor-erythroid-2-related factor 2 (Nrf2), a member of 
the CNC (Cap’n’Collar) subfamily of the bZIP (basic leucine zipper) 
transcription factor family, is responsible for the induction of genes 
encoding anti-oxidative, stress responsive, or anti-inflammatory 
cellular mediators (Itoh, Chiba et al. 1997, Alam, Stewart et al. 1999, 
Surh, Kundu et al. 2008). In normal conditions, Nrf2 is degradated in 
the cytosol via interactions with Keap1 (Kelch-like ECH associating 
protein 1). By the cellular stresses or small molecular inducers, 
including reactive oxygen species, ER stress, heavy metals, Michael 
acceptors, Keap1 is dissociated from Nrf2. As a consequence, stabilized 
Nrf2 is accumulated in the nucleus, and binds to antioxidant response 
element (ARE) of promoter region (Kensler, Wakabayashi et al. 2007, 
Padmanabhan, Tong et al. 2008). 
Activating transcription factor 3 (ATF3), is a member of the 
ATF/CREB (ATF/cyclic AMP response element-binding) family of 
bZIP transcription factors. The ATF/CREB family members are 
consisted with bZIP element containing proteins including ATF1-7, 
CREB, CTEM, b-ATF (Thompson, Xu et al. 2009), and bind to the 
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consensus sequence (Deutsch, Hoeffler et al. 1988). Among these 
transcription factors, ATF3 has roles as transcriptional activators or 
repressors depending on various contexts (Chen, Liang et al. 1994). For 
example, the ATF3/c-JUN heterodimer has increased the transcription 
in response to an EGF (epidermal growth factor) stimulation (Nilsson, 
Ford et al. 1997). Whereas, metformin induced ATF3 has shown to 
repress LPS-induced TNFα and IL-6 production in murine 
macrophages (Kim, Kwak et al. 2014). Numerous investigations using 
ATF3-deficient mice model suggest that ATF3 regulates inflammatory 
target genes including Il12p40, Il-6, Il-12b, Ifn-γ, and Ccl4 as 
transcriptional repressors (Gilchrist, Thorsson et al. 2006, Khuu, 
Barrozo et al. 2007, Whitmore, Iparraguirre et al. 2007, Thompson, Xu 
et al. 2009). Multiple signaling pathways are involved in induction of 
ATF3 as an inducer, which are ERK, JNK, and p38 signaling pathways 
(Lu, Chen et al. 2007). Moreover, previous studies showed that ATF3 
transcription was induced by Nrf2 transcription factor in human 
astrocyte and monocyte (Kim, Jeong et al. 2010, Hoetzenecker, 
Echtenacher et al. 2012). 
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PURPOSE OF THIS STUDY 
 
The various roles of Ninjurin1 in macrophages has been 
reported, such as increasing adhesion to endothelial cells and motility 
during early ocular development and EAE. Moreover, it was recently 
revealed that Ninjurin1 modulates the TLR4-dependent inflammatory 
response triggered by LPS via p38 phosphorylation and activator 
protein-1 (AP1) activation; however, the precise mechanism of its roles 
in the inflammatory response is enigmatic.  
This study reports that Ninjurin1 mediates LPS-induced 
inflammation by directly binding to LPS. Additionally, the role of 2-
MCA in macrophage inflammation was examined for finding a 
chemical regulator of inflammation. It is expected that these 
identifications provide an important insight into the regulation of 
macrophage-mediated inflammatory response and diseases. 
 １６
MATERIALS AND METHODS 
 
1. Cell culture 
HEK293T and Raw264.7 cells were obtained from the 
American Type Culture Collection (ATCC, Manassas, VA, USA) and 
the Korean Cell Line Bank (KCLB, Seoul, KOREA), respectively. 
Cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM, 
GenDEPOT, Barker, TX, USA) supplemented with 10 % fetal bovine 
serum (FBS, GenDEPOT), and 100 U/ml penicillin and 100 μg/ml 
streptomycin (GenDEPOT) at 37 ℃ in a humidified 5 % CO2 
atmosphere. 
Bone marrow-derived primary macrophages were isolated from 
mice according to a previously published method (Gonçalves and 
Mosser 2001). Cells were cultured in DMEM/F12 medium 
(GenDEPOT) supplemented with 10 % FBS, 20 % L929 conditioned 
medium, 1× GlutaMAX (Gibco, Grand Island, NY, USA), and 100 
U/ml penicillin and 100 μg/ml streptomycin at 37 ℃ in a humidified 
5 % CO2 atmosphere. 
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2. Construction of expression plasmids and transfection 
Expression plasmids for human (NM_004148) and mouse 
(NM_013610) Ninjurin1 were constructed as described previously (21). 
To construct expression plasmids for N-terminal MYC-tagged human 
and mouse Ninjurin1, cDNA were amplified by PCR and subcloned 
into pCS2+-Myc. Truncated forms of mouse Ninjurin1, MYC-mNINJ1 
(1–71), MYC-mNINJ1 (72–152), MYC-mNINJ1 (1–100), MYC-
mNINJ1 (1–90), MYC-mNINJ1 (1–80), MYC-mNINJ1 (81–152), 
MYC-mNINJ1 (91–152), and MYC-mNINJ1 (101–152) plasmids were 
also constructed using pCS2+-Myc as backbone. Designing and cloning 
of the expression plasmid of non-tagged Ninjurin1 was described 
previously (23). Briefly, mouse Ninjurin1 cDNA was subcloned into 
pcDNA3.1+ myc/his backbone without removing a stop codon. 
 
3. RNA interference 
Ninjurin1 downregulation was performed with RNA 
interference. siNinj1 targeted to mouse Ninjurin1 was purchased from 
Life Technologies (Grand Island, NY, USA). Negative control of RNA 
interference, siControl that has scrambled sequence was purchased 
from Bioneer (Daejeon, Korea). The following sequences were used: 
 １８
siControl: 5’-CCTACGCCACCAAUUUCGUdTdT-3’; siNinj1: 5’-
ACCGGCCCAUCAAUGUAAACCAUUA-3’. Raw264.7 cells at 
2×105 cells/dish were cultured in 60 mm culture dishes for 12 h. 20 nM 
siRNAs were transfected using Lipofectamine RNAiMAX Transfection 
Reagent (Life Technologies). After 24 h of transfection, media was 
changed with presence or absence of 1 μg/ml LPS (Sigma-Aldrich). 
After another 24 h, cultured supernatant and cells were collected. 
 
4. Immunoblot analysis 
Proteins were extracted in cell lysis buffer containing 50 mM 
Tris-Cl (pH 7.4), 300 mM NaCl, 5 mM EDTA, 0.02 % (w/v) sodium 
azide, 1 % (w/v) Triton X-100, 10 mM iodoacetamide, 1 mM 
phenylmethanesulfonyl fluoride, 2 μg/ml leupeptin, and protease 
inhibitor cocktail (Calbiochem, Billerica, MA, USA). Lysates were 
separated with SDS-PAGE and transferred to nitrocellulose membrane 
(GE Healthcare Life Sciences, Pittsburgh, PA, USA). The transferred 
membrane was probed with the specific antibodies. Antibodies to 
NOS2 were purchased from BD Bioscience (San Diego, CA, USA), 
MYC, GAPDH, c-JUN, c-FOS, ATF3, LaminA, and Actin purchased 
from Santa Cruz Biotechnology (Dallas, TX, USA), p38, p-p38 
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(Thr180/Tyr182), p44/42, p-p44/42 (Thr202/Tyr204), JNK, p-JNK 
(Thr183/Tyr185), IKKα, IKKβ, p-IKKα/β (Ser176/Ser180), Nrf2, IκBα, 
p65, p-p65 (Ser536) purchased from Cell Signaling Technology 
(Danvers, MA, USA), HO-1 purchased from Enzo Life Sciences 
(Farmingdale, NY, USA). Endogenous Ninjurin1 was detected by 
custom-made antibody that was raised in rabbit with aa 1-15 and aa 
139–152 of mouse Ninjurin1 (Ninj1 Ab1-15 and Ninj1 Ab139–152, 
respectively) (23). Image was acquired using LAS3000 machine (GE 
Healthcare Life Sciences).  
 
5. Immunoprecipitation and silver staining 
1000 μg of protein lysates and 1 μg of MYC antibody or 0.4 μg 
of Ninj1 Ab1-15 antibody were incubated overnight at 4 ℃ with gentle 
rotation. 10 μl of protein A agarose beads (EMD Millipore, Billerica, 
MA, USA) were added to each samples and the mixture was incubated 
at 4 ℃ for 4 h with gentle rotation. After washing 5 times with washing 
buffer containing 50 mM Tris-Cl (pH7.4), 300 mM NaCl, 5 mM EDTA, 
0.02 % (w/v) sodium azide, and 0.1 % (w/v) Triton X-100, precipitated 
proteins were eluted by boiling with SDS sample buffer at 95 ℃ for 10 
min. The eluted sample was separated with SDS-PAGE followed by 
 ２０
silver staining procedure using PlusOne Silver Staining kit (GE 
Healthcare Life Sciences) recommended by manufacturing company. 
 
6. GST pull-down assay 
GST-tagged aa 1-71 of human Ninjurin1, GST-hNINJ1 (1-71), 
was purified from BL21 (DE3) E. coli transformed with pGEX-4T-2-
hNinj1 (1-71) plasmid. 10 μl of glutathione sepharose beads (GE 
Healthcare Life Sciences) conjugated GST-hNinj1 (1-71) was added to 
4 mg of mouse liver lysates and incubated at 4 ℃ for 24 h with gentle 
rotation. After washing 5 times with washing buffer, pulled-down 
proteins were eluted by boiling with SDS sample buffer at 95 ℃ for 10 
min. The eluted sample was separated with SDS-PAGE followed by 
silver staining. 
 
7. Protein cross-linking with chemical cross-linkers 
HEK293T cells were detached from culture dishes by 10 mM 
EDTA or mouse liver were dissociated by gentleMACS dissociator 
(Miltenyi Biotec, Bergisch Gladbach, Germany). Cells were suspended 
to 2.5 × 107 cells/ml in PBS buffer (pH 8.0), and added chemical cross-
linkers such as 1 % to 4 % paraformaldehyde (PFA), 5 mM 
 ２１
bis(sulfosuccinimidyl) suberate (BS3), or 5 mM disuccinimidyl 
suberate (DSS) at the final concentration. After incubated at room 
temperature (RT) for 30 min, cross-linker was quenched by 1 M Tris-
HCl for PFA or 20 mM Tris-HCl for BS3 and DSS at RT for 15 min. 
And then, cells were lysed, and cross-linked proteins were detected by 
immunoblot analysis and silver staining. 
 
8. Binding assay of Ninjurin1 with MALP-2 
2 μg of macrophage-activating lipopeptide-2 (MALP-2, Enzo 
Life Sciences) was conjugated to NHS-activated agarose beads (Life 
Technologies) recommended by manufacturing company. 500 μg of 
protein lysates and MALP-2 conjugated beads were incubated 
overnight at 4 ℃ with gentle rotation. After washing 5 times with 
washing buffer, binding proteins were eluted by boiling with SDS 
sample buffer at 95 ℃ for 10 min. The eluted samples were further 
analyzed by immunoblot analysis. 
 
9. Binding assay of Ninjurin1 with LPS 
500 μg of protein lysates and 4 μg of LPS-biotin (InvivoGen, 
San Diego, CA, USA) were incubated overnight at 4 ℃ with gentle 
 ２２
rotation. 10 μl of streptavidin sepharose beads (GE Healthcare Life 
Sciences) was added to each samples and incubated at 4 ℃ for 2 h with 
gentle rotation. After washing 5 times with washing buffer, binding 
proteins were eluted by boiling with SDS sample buffer at 95 ℃ for 10 
min. The eluted samples were further analyzed by immunoblot analysis. 
 
10. Binding assay of Ninjurin1 with LPS on live primary 
macrophages 
Bone marrow-derived primary macrophages form WT and 
Ninjurin1 KO were plated into 60 mm culture dishes at 3×106 cells/dish. 
After 24 h of culture, media was changed with or without LPS-biotin (1 
μg/ml). After incubation, cells were washed unbound LPS-biotin 3 
times using PBS, and then harvested, and lysed. Lysates were separated 
by SDS-PAGE and transferred to nitrocellulose membrane. Bound 
LPS-biotin was detected using streptavidin-HRP (Pierce, Grand Island, 
NY, USA). 
 
11. Binding assay of recombinant HIS-hNINJ1 with LPS 
Histidine tagged human Ninjurin1 protein (HIS-hNINJ1) was 
purified from C43 (DE3) E. coli transformed with pET17-His-hNinj1 
 ２３
(2-152) plasmid. 2 μg of HIS-hNINJ1 and 10 μg of LPS-biotin were 
incubated at 4 ℃ for 4 h with gentle rotation. And then, 10 μl of 
streptavidin sepharose beads was added to each sample and incubated 
at 4 ℃ for 2 h with gentle rotation. After washing 5 times with washing 
buffer, binding proteins were eluted by boiling with SDS sample buffer 
at 95 ℃ for 10 min. The eluted samples were further analyzed by 
immunoblot analysis using streptavidin-HRP and HIS antibody (Santa 
Cruz Biotechnology). 
 
12. Mass spectrometry 
Candidate protein bands excised from silver stained gels were 
destained with destaining solution that consisted of 30 mM potassium 
ferricyanide and 100 mM sodium thiosulfate for 5 min and then 
incubated with 200 mM ammonium bicarbonate for 20 min. The gels 
were dehydrated with acetonitrile and dried in a vacuum centrifuge. 
The dried gels were rehydrated with 50 mM ammonium bicarbonate 
containing 200 ng trypsin (Promega, Madison, WI, USA) for 45 min, 
replaced solution to 50 mM ammonium bicarbonate, and incubated 
overnight at 37 ℃. Digested peptide was purified using a desalting 
column (GE loader tip, Eppendorf, Hamburg, Germany). Each peptide 
 ２４
sample was applied to ESI-Q-TOF MS/MS spectrometer (ABSciex, 
Framingham, MA, USA). The deduced peptide sequence after MS/MS 
was analyzed by MASCOT search engine 
(http://www.matrixscience.com) against Swiss-Prot and NCBI 
databases. 
 
13. Measuring endocytosis of LPS 
Primary macrophages from WT and Ninjurin1 KO mice were 
plated into 6 well plate at 2×106 cells/well for 12 h and then treated 
FITC conjugated LPS (LPS-FITC, sigma) at 1 μg/ml concentration for 
24 h. Endocytosed LPS-FITC was observed using microscope (LSM 
700 , Zeiss, Oberkochen, Germany) and quantified using flow 
cytometer (FACSVerse, BD Bioscience). 
 
14. Macrophage phagocytosis assay 
Primary macrophages from WT and Ninjurin1 KO mice were 
plated into 96 well plate at 4×104 cells/well for 12 h and then treated 
pHrodo E. coli particle (Life Technologies) at 0.2 mg/ml concentration 
for 24 h. Phagosomes were observed using microscope and quantified 




15. Nitric oxide (NO) assay 
Raw264.7 cells were plated into 60 mm culture dishes at 2×105 
cells/dish for 12 h and then transfected with Ninj1 or negative control 
siRNA. After 24 h of culture, media was changed with or without LPS 
(1 μg/ml). After incubation for 24 h, the cultured supernatant was 
collected and removed cells by centrifugation at 500 g for 3 min. To 
evaluate an effect of 2-MCA, Raw264.7 cells and primary macrophages 
were plated into 60 mm culture dishes at 5×105 and 1×106 cells/dish for 
12 h and then pre-treated serial diluted 2-MCA. After 4 h of culture, 
media was added with or without LPS (final concentration, 1 μg/ml). 
After incubation for 24 h, the cultured supernatant was collected and 
removed cells by centrifugation at 500 g for 3 min. 
100 μl of the cultured supernatant was mixed with 100 μl of 
Griess reagent (1:1 mixture of 1 % sulfanilamide in 30 % acetate and 
0.1 % N-1-naphthylethylenediamine dihydrochloride in 60 % acetate) 
at RT for 10 min. The absorbance of the incubated samples was 
measured using microplate reader at 540 nm. A standard curve drawn 
with known concentrations of sodium nitrite was applied to calculate 
 ２６
the concentration of nitrite, the stable end product of NO. 
 
16. Measurement of TNFα secretion 
Raw264.7 cells were cultured in 96 well culture plates at 1×104 
cells/well for 12 h. The Raw264.7 cells were transfected with Ninj1 or 
negative control siRNA for 24 h and then media was removed and 
replaced with 200 μl of fresh media with or without LPS (1 μg/ml). 
After 24 h of incubation, the cultured supernatant was collected. To 
evaluate an effect of 2-MCA, Raw264.7 cells and primary macrophages 
were cultured in 96 well culture plates at 1×104 and 2×104 cells/well for 
12 h and then pre-treated serial diluted 2-MCA. After 4 h of culture, 
media was added with or without LPS (final concentration, 1 μg/ml). 
After 24 h of incubation, the cultured supernatant was collected. 
The amount of secreted TNFα was measured using Mouse 
TNFα ELISA MAX kit (BioLegend, San Diego, CA, USA) as the 
manufacturer’s instructions. 
 
17. Cell viability assay 
Raw264.7 cells and primary macrophages were seeded into 96 
well plate at 1×104 and 2×104 cells/well, respectively. After 12 h 
 ２７
incubation, serial diluted 2-MCA was treat for 24 h. Cell viability was 
measured by reduction of  [3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS, 
Promega). Cultured medium were changed to MTS containing medium, 
and then incubated 1 h for MTS reduction by viable cell 
dehydrogenases. The soluble formazan product of MTS was measure at 
490 nm. 
 
18. pFPR fluorescence protein reporter assay 
Fluorescence protein reporter vector, pFPR, was constructed by 
Gibson assembly (Gibson, Young et al. 2009). 6 dsDNA fragments, 
derived from PCR amplification and enzyme digestion of plasmid, and 
Gibson Assembly Mater Mix (New England Biolabs, Ipswich, MA, 
USA) containing 5′ Exonuclease, DNA polymerase, and DNA ligase 
were mixed together, and incubated at 50°C for 60 min. After 
incubation, mixture was transformed to competent E. coli. pFPR-NF-
κB was constructed by Gibson assembly with sense- and antisense- 
fragments of NF-κB Transcription response element (TRE) and enzyme 
digested pFPR plasmid (Table 2). 
Raw264.7 cells were stably transduced pFPR and pFPR-NF-κB 
 ２８
plasmid. pFPR and pFPR-NF-κB stable Raw264.7 cells were plated 
into 60mm culture dishes at 5×105 cells/dish for 12 h and then pre-
treated 50 μM 2-MCA. After 4 h of culture, media was added with or 
without LPS (final concentration, 1 μg/ml). Fluorescence of mCerulean 
and mCherry was detected by microscope (LSM 700, Zeiss, 
Oberkochen, Germany) and flow cytometer (FACSVerse, BD 
Bioscience). 
 
19. Statistical analysis 
All data were presented as the mean ± SD. The differences 
between groups were analyzed by the unpaired two-tailed Student’s t-
test. p < 0.05 denoted the presence of statistical significance. 
 ２９




1. Candidates of the Ninjurin1 binding partner are discovered in 
immunoprecipitation using Ninj1 Ab1-15 antibody. 
 
At the start of this study, immunoprecipitation, gel separation 
and silver staining was performed to discover novel Ninjurin1 binding 
partners. For this, total lysates from mouse liver were 
immunoprecipitated with Ninj1 Ab1-15 or rabbit IgG antibody, separated 
by SDS-PAGE, and then stained with silver nitrate. Notably, this study 
found the candidates of the Ninjurin1 binding partner (Figure 4, 
arrowhead) that co-immunoprecipitated with endogenous Ninjurin1 
protein (Figure 4, arrow), but they were not observed in the control 
sample. 
 ３１
Mouse liver lysates (2 mg) were immunoprecipitated using Ninj1 Ab1-15 
or rabbit IgG antibody. Immunoprecipitated and co-immunoprecipitated 
proteins were separated by SDS-PAGE and stained with silver nitrate. 
The arrow indicates immunoprecipitated mNINJ1 and arrowheads 
indicate candidates of Ninjurin1 binding partner. 14 % acrylamide gel 
used for smaller sized proteins (A) and 7 % acrylamide gel was used 
for larger sized proteins (B).  
Figure 4. Co-immunoprecipitated protein with Ninjurin1. 
 ３２
2. Candidates of the Ninjurin1 binding partner are discovered by 
GST pull-down assay. 
 
To discover more candidates of the Ninjurin1 binding partner, 
this study performed pull-down assay using GST tagged recombinant 
human Ninjurin1, GST-hNINJ1 (1-71). Markedly, this study found 
several proteins (Figure 5, arrowhead) that pulled-down with GST-
hNINJ1 (1-71) protein (Figure 5, arrow), but they were not observed in 
the control sample. 
 
 ３３
Mouse liver lysates (2 mg) were pulled-down using GST tagged 
recombinant human Ninjurin1 protein, GST-hNINJ1 (1-71), and 
glutathione sepharose beads. The same process was used for control 
samples (Cont.) without GST-hNINJ1 (1-71). Pulled-down proteins 
were separated by SDS-PAGE and stained with silver nitrate. The 
arrow indicates GST-hNINJ1 (1-71) and arrowheads indicate 
candidates of Ninjurin1 binding partner. 
Figure 5. Pulled-down protein with GST-hNINJ1 (1-71). 
 ３４
3. Candidates of the Ninjurin1 binding partner are discovered in 
immunoprecipitation using MYC antibody. 
 
HEK293T cells were transfected with MYC-tagged human 
Ninjurin1 (MYC-hNINJ1) or empty control (Mock) plasmid. Total 
lysates from transfected HEK293T cells were immunoprecipitated with 
MYC antibody, separated by SDS-PAGE, and then stained with silver 
nitrate. Notably, this study found candidates of the Ninjurin1 binding 
partner (Figure 6, arrowheads) that co-immunoprecipitated with ~36 
kDa MYC-hNINJ1 protein (Figure 6A, arrow), but they were not 
observed in the control sample. As a control, MYC-hNINJ1 expression 
was confirmed by immunoblot analysis with MYC antibody (Figure 6A, 
lower). 
 ３５
HEK293T cells were transfected with expression plasmid of MYC-
hNINJ1 paralleling with empty control (Mock) plasmid. Cell lysates 
(1000 μg) were immunoprecipitated using MYC antibody and agarose 
A beads. Precipitated proteins were separated by SDS-PAGE and 
stained by silver nitrate. The arrow indicates MYC-hNINJ1 and 
arrowhead indicates candidates of Ninjurin1 binding partner. 
Expression of MYC-hNINJ1 was detected by immunoblot analysis 
with MYC antibody using 30 μg of lysates (A lower). 10 % acrylamide 
gel used for smaller sized proteins (A) and 7 % acrylamide gel was 
Figure 6. Co-immunoprecipitated protein with MYC-hNINJ1. 
 ３６
used for larger sized proteins (B). 
 ３７
4. Candidates of the Ninjurin1 binding partner are discovered by 
cross-linking using paraformaldehyde. 
 
Protein cross-linking by chemical cross-linker was applied for 
finding the Ninjurin1 binding partner. Three kinds of chemical cross-
linkers, PFA, BS3, and DSS, treated to MYC-hNINJ1 over-expressed 
HEK293T cells (Figure 7) or mouse liver cells (Figure 8). In the 
experiment using HEK293T cells, size-shifted protein bands were 
detected by MYC antibody, but was not observed in the non-transfected 
(-) samples. However, since non-treated sample (NT) also had protein 
bands with similar molecular weight range, it made difficulties in 
distinguishing the Ninjurin1 binding complex (Figure 7). On the other 
hands, the experiment using mouse liver cells showed size-shifted 
protein bands detected by Ninj1 Ab1-15 or Ninj1 Ab139-152 antibodies. All 
of three chemical cross-linkers showed size-shifted protein bands, but 
only PFA treated sample had no detected band in KO samples. Non-
treated sample (NT) had no detectable size-shifted protein bands 
(Figure 8). 
To optimize cross-linking condition by PFA, various 
concentration and treatment time were examined (Figure 9). 4 % PFA 
 ３８
presented the most obvious difference among the tested concentration, 
1 %, 2 %, and 4 % PFA. Size-shifted protein bands were increased 
along with the treatment time. To comprehend optimizing results, 4 % 
concentration and 30 min treatment time was selected for cross-linking 
assay. 
Cross-linking assay was shown that size-shifted protein bands 
were considered as cross-linked complexes of Ninjurin1 and adjacent 
protein (Figure 10A, arrowheads). To prepare protein band suitable for 
mass spectrometry analysis, silver staining was performed with 
immunoprecipitated cell lysates using Ninj1 Ab139-152 antibody. 
Endogenous Ninjurin1 protein was well immunoprecipitated (Figure 
10B, arrow), however there was no detectable size-shifted protein band, 
in WT sample compare with KO sample. 
 ３９
HEK293T cells were transfected with expression plasmid of MYC- 
hNINJ1. After the incubation, cells were detached and treated chemical 
cross-linkers for 30 min. 1 % PFA, 5 mM BS3, and 5mM DSS were 
used as chemical cross-linkers. Cells were lysed, and cross-linked 
proteins were detected by immunoblot analysis with MYC antibody. 
NT, non-treated; －, non-transfected cell; ＋, MYC-hNINJ1 
transfected cell. 
Figure 7. Cross-linking of MYC-hNINJ1 using PFA, BS3, and
DSS. 
 ４０
WT and Ninjurin1 KO mouse liver was dissociated and treated 
chemical cross-linkers for 30 min. 1 % PFA, 5 mM BS3, and 5 mM 
Figure 8. Cross-linking of mouse liver cell using PFA, BS3, and
DSS. 
 ４１
DSS were used as chemical cross-linkers. Cells were lysed, and cross-
linked proteins were detected by immunoblot analysis with Ninj1 Ab1-15 
(A) or Ninj1 Ab139-152 (B). NT, non-treated. 
 ４２
WT and Ninjurin1 KO mouse liver was dissociated and cross-linked 
with various conditions of PFA. Cells were lysed, and cross-linked 
proteins were detected by immunoblot analysis with Ninj1 Ab139-152 
antibody. (A) Cross-linking activity through the concentration of PFA 
Figure 9. Optimization of PFA mediated cross-linking conditions. 
 ４３
was examined. 1 %, 2 %, and 4 % PFA was treated for cross-linking of 
mouse liver protein. (B) Cross-linking activity through the treatment 
time of PFA was examined. 4 % PFA was treated for 10, 30, and 60 min. 
NT, non-treated. 
 ４４
WT and Ninjurin1 KO mouse liver was dissociated and cross-linked 
with 4 % PFA for 30 min. Cells were lysed, and cross-linked proteins 
were subjected to immunoblot analysis or immunoprecipitation. (A) 
Cell lysates (40 μg) were separated by SDS-PAGE and immunoblotted 
with Ninj1 Ab139-152 antibody. (B) Cell lysates (2000 μg) were 
immunoprecipitated using MYC antibody and agarose A beads. 
Precipitated proteins were separated by SDS-PAGE and stained by 
silver nitrate. Arrows indicates MYC-hNINJ1 and arrowheads indicate 
candidates of Ninjurin1 and Ninjurin1 binding partner complex. 12 % 
Figure 10. Size-shifted proteins by PFA mediated cross-linking. 
 ４５
acrylamide gel was used for smaller sized proteins (A and B left) and 
7 % acrylamide gel was used for larger sized proteins (A and B right). 
 ４６
5. Identification of Ninjurin1 binding partners by mass 
spectrometry. 
 
The ~47 kDa band (Figure 6A) and the ~42 kDa band (Figure 
5) were excised and analysed by mass spectrometry in order to identify 
the protein of interest. The resulting ESI-MS spectrum presented with 
m/z peaks ranging from 750 to 850 (Figure 11A) and 900 to 1000 
(Figure 12A) respectively.  
The peak at 793.9 m/z from the ~47 kDa band was sequenced 
and identified as a 14-amino acid peptide (IFSPATVFFTSIEK) in 
further MS/MS analysis (Figure 11B). Unexpectedly, queries in the 
Swiss-Prot and NCBI databases using the MASCOT search engine 
revealed that the peptide sequence was identical to aa 317–330 of Ag 
243-5 (BAA04082), mycoplasmal lipoprotein (Figure 11C). To find out 
the reason for mycoplasma protein existence in our HEK293T cell 
lysates, this study tested our cells for mycoplasma and found that the 
HEK293T cells used in the analysis were positive for contamination. 
Subsequent analyses revealed that non-contaminated HEK293T cell 
lysates did not contain this ~47 kDa protein band (data not shown). 
Although unexpected, these observations were intriguing since several 
 ４７
previous reports demonstrated a role for Ninjurin1 in the inflammatory 
response, but the precise mechanism was unknown. Thus, this study 
hypothesized that Ninjurin1 could recognize microbial pathogens 
conjugated with lipid moieties, such as mycoplasma lipopeptide 
MALP-2 and LPS. 
The peak at 981.53 m/z from the ~42 kDa band was sequenced 
and identified as a 17-amino acid peptide (IIELAGFLDSYIPEPER) in 
further MS/MS analysis (Figure 12B). Queries in the Swiss-Prot and 
NCBI database using the MASCOT search engine revealed that the 
peptide sequence was identical to aa 189–205 of elongation factor Tu 
(WP_003031109.1) (Figure 12C). The ~42 kDa band was found in a 
pull-down experiment using GST-hNINJ1 purified from E. coli. 
Therefore the identified protein was assumed to come from GST-
hNINJ1 purification process. 
 ４８
(A) ESI-MS spectrum of trypsin-digested of the ~47 kDa protein band 
(Figure 6A). The peak at 793.9 m/z (marked with asterisks) was 
subjected in further MS/MS analysis. (B) The MS/MS spectrum was 
Figure 11. Identification of the Ag 243-5 protein by ESI-MS/MS
analysis. 
 ４９
identified as the partial tryptic peptide IFSPATVFFTSIEK. (C) 
Database searching with Swiss-Prot and NCBI protein databases. 
Peptide sequence (Bold) was matched with aa 317–330 of M. arginini 
protein Ag 243-5. 
 ５０
(A) ESI-MS spectrum of trypsin-digested of the ~42 kDa protein band 
(Figure 5). The peak at 981.53 m/z (marked with asterisks) was 
subjected in further MS/MS analysis. (B) The MS/MS spectrum was 
identified as the partial tryptic peptide IIELAGFLDSYIPEPER. (C) 
Figure 12. Identification of the elongation factor Tu protein by
ESI-MS/MS analysis. 
 ５１
Database searching with Swiss-Prot and NCBI protein databases. 
Peptide sequence (Bold) was matched with aa 189–205 of 
Enterobateriaceae protein elongation factor Tu. 
 
 ５２
6. Ag 243-5, MALP-2, and LPS bind to human and mouse 
Ninjurin1. 
 
Ag 243-5 protein and human Ninjurin1 binding was identified 
from co-immunoprecipitation and mass spectrometry analysis. To 
examine whether the Ag 243-5 protein binds to mouse Ninjurin1, 
immunoprecipitations were repeated with lysates from HEK293T cells 
transfected with MYC-tagged mouse Ninjurin1 (MYC-mNINJ1). 
Significantly, both hNINJ1 and mNINJ1 were capable of pulling-down 
the Ag 243-5 protein (Figure 13). As a control, the MYC-h/mNINJ1 
expression was confirmed by immunoblot analysis with MYC antibody 
(Figure 13, lower). 
Both MALP-2 and LPS are bacterial endotoxins that induce 
inflammatory macrophage activation in a manner dependent on their 
lipid moieties. Therefore, this study tested whether MALP-2 and LPS 
were also able to bind Ninjurin1 as observed with Ag 243-5. For this, 
MYC-h/mNINJ1 over-expressed HEK293T cell lysates were incubated 
with MALP-2-conjugated beads, and the bound proteins were eluted 
and examined by immunoblot analysis. The same process was used for 
control samples with unconjugated beads. Results showed that human 
 ５３
and mouse Ninjurin1 were efficiently pulled-down with MALP-2 beads 
(Figure 14A), but not control samples. In the case of LPS-biotin, 
Ninjurin1-expressing cell lysates were incubated with or without LPS-
biotin and streptavidin sepharose beads. Similar to the observation from 
MALP-2, human and mouse Ninjurin1 were both able to bind LPS-
biotin (Figure 14B). To rule out the possibility of an interaction 
between the MYC peptide tag and LPS, LPS binding was assessed 
using lysates from HEK293T cells transfected with non-tagged mouse 
Ninjurin1 (mNINJ1) plasmid. As expected, non-tagged mouse 
Ninjurin1 also bound LPS-biotin (Figure 14C). 
 ５４
HEK293T cells were transfected with expression plasmid of MYC-
h/mNINJ1 paralleling with empty control (Mock) plasmid. Cell lysates 
(1000 μg) were immunoprecipitated using MYC antibody and agarose 
A beads. Precipitated protein was separated by SDS-PAGE and stained 
by silver nitrate. The arrow indicates MYC-h/mNINJ1 and the 
arrowhead indicates an Ag 243-5 protein. The expression of MYC-
h/mNINJ1 was detected by immunoblot analysis with MYC antibody 
using 30 μg of lysates (lower). 
Figure 13. Binding of the Ag 243-5 protein with human or mouse
Ninjurin1 protein in immunoprecipitation with MYC antibody. 
 ５５
MYC-h/mNINJ1 (A, B) or mNINJ1 (C) were expressed in HEK293T 
cells. (A-C) Cell lysates (500 μg) and mycoplasma lipoprotein MALP-2 
(2 μg) or LPS-biotin (4 μg) were mixed and pulled-down by 
conjugating with beads or streptavidin beads, respectively. Binding of 
the Ninjurin1 protein to MALP-2 or LPS was detected with MYC (A 
and B) or Ninj1 Ab139–152 (C) antibodies.  
Figure 14. Binding assay between Ninjurin1 and MALP-2 or LPS. 
 ５６
7. Characterization of binding between Ninjurin1 and LPS. 
 
To examine whether the binding between Ninjurin1 and LPS 
occurs in live cells, LPS-biotin was treated to live cells. After 
incubation, un-bounded LPS-biotin was washed out. Cells were 
harvested, and bounded LPS-biotin was detected. LPS-biotin bound to 
primary macrophage from WT mouse, but binding was markedly 
reduced in primary macrophages from Ninjurin1 KO mouse (Figure 15). 
Next, to exclude an indirect binding via adaptor protein, two 
kinds of approaches were conducted. First, MYC-mNINJ1 was 
immobilized using MYC antibody, washing away non-binding 
molecules and then adding LPS-biotin for instance. The effectiveness 
of wash-out was verified by silver staining (Figure 16A). LPS-biotin 
could bind to Ninjurin1 without adaptive proteins (Figure 16B). Second, 
recombinant histidine tagged Ninjurin1 protein was used for LPS 
binding assay. The purity of recombinant protein was tested in silver 
staining (Figure 17A). Recombinant histidine tagged Ninjurin1 also 
bound to LPS (Figure 17B). 
In addition, to specify the region of Ninjurin1 responsible for 
LPS binding, truncated mouse Ninjurin1 expression plasmids were 
 ５７
constructed. MYC-mNINJ1 (1–71) and MYC-mNINJ1 (72–152), 
encoding the extracellular N-terminal region and the two 
transmembranes, cytosolic, and extracellular C-terminus domains, 
respectively, were cloned into pCS2+-Myc backbone plasmid. Full 
length MYC-mNINJ1, MYC-mNINJ1 (1–71), and MYC-mNINJ1 (72–
152) were transfected to HEK293T cells, and the expression was 
confirmed by immunoblot analysis (Figure 18, lower). LPS binding 
assays were then performed using equal amounts of cell lysates and 
LPS-biotin (Figure 18, upper). Results showed that full-length MYC-
mNINJ1 and MYC-mNINJ1 (72–152) bound LPS, whereas MYC-
mNINJ1 (1–71) did not. To further delineate the binding region within 
Ninjurin1, additional expression plasmids of the truncated N- and C-
terminals of mouse Ninjurin1 were constructed as follows: MYC-
mNINJ1 (1–100), MYC-mNINJ1 (1–90), MYC-mNINJ1 (1–80), 
MYC-mNINJ1 (81–152), MYC-mNINJ1 (91–152), MYC-mNINJ1 
(101–152), and MYC mNINJ1 (71–100). Ninjurin1 mutant expression 
was then examined by immunoblot analysis (Figure 19A and Figure 
19B, lower). Notably, binding assays demonstrated that MYC-mNINJ1 
(1–100), MYC-mNINJ1 (1–90), MYC-mNINJ1 (81–152), MYC-
mNINJ1 (91–152), and MYC-mNINJ1 (71–110) bound LPS, whereas 
 ５８
MYC-mNINJ1 (1–80) and MYC-mNINJ1 (101–152) did not (Figure 
19A and Figure 19B, upper). The binding abilities of these recombinant 
Ninjurin1 mutant proteins are summarized in Figure 20, which 
indicates that the aa 81–100 region of Ninjurin1 is required for LPS 
binding. 
 ５９
Bone marrow-derived macrophage from WT and Ninjurin1 KO mice 
were cultured on 60 mm culture dishes. LPS-biotin (1 μg/ml) was 
treated to live cells. After incubating for the indicated time, wash-out 
unbounded LPS-biotin. Cells were harvested, and bounded LPS-biotin 
was detected by streptavidin-HRP. Endogenous Ninjurin1 expression 
was detected by Ninj1 Ab139–152 antibody. 
Figure 15. Binding of LPS and Ninjurin1 on live cells. 
 ６０
HEK293T cells were transfected with expression plasmid of MYC- 
mNINJ1 paralleling with Mock plasmid. Cell lysates (1000 μg) were 
immunoprecipitated with MYC antibody, the unbound proteins were 
washed away, and LPS-biotin (10 μg) was then added. The protein was 
washed and immunoprecipitated, followed by staining with silver 
nitrate (A) and the binding of LPS to Ninjurin1 protein was detected 
using streptavidin-HRP (B). The arrow indicates MYC-mNINJ1. 
Figure 16. LPS-biotin binding with washed MYC-mNINJ1
conjugated beads. 
 ６１
(A) Histidine tagged human Ninjurin1 protein (HIS-hNINJ1) was 
purified from E. coli. Purity of recombinant HIS-hNINJ1 was examined 
by silver nitrate staining. The arrow indicates HIS-hNINJ1. (B) HIS-
hNINJ1 (2 μg) was incubated with or without LPS-biotin (10 μg) and 
pulled-down by streptavidin beads. Binding of HIS-hNINJ1 to LPS was 
detected with HIS antibody. Pulled-down LPS-biotin was detected by 
streptavidin-HRP. 
 
Figure 17. LPS-biotin binding with recombinant histidine tagged
human Ninjurin1. 
 ６２
Binding assay between LPS and MYC-tagged mouse Ninjurin1 
fragments, MYC-mNINJ1 (1–71) and MYC-mNINJ1 (72–152). The 
expression of transfected mNINJ1 constructs was detected by 
immunoblot analysis with MYC antibody (lower). Bindings between 
LPS and truncated Ninjurin1 were tested (upper). 
Figure 18. The aa 72–152 region of Ninjurin1 binds to LPS. 
 ６３
(A) Binding assay between LPS and MYC-mNINJ1 (1–100), MYC-
mNINJ1 (1–90), MYC-mNINJ1 (1–80), MYC-mNINJ1 (81–152), 
MYC-mNINJ1 (91–152), and MYC-mNINJ1 (101–152). (B) Binding 
Figure 19. The aa 81–100 region of Ninjurin1 is responsible for
LPS binding. 
 ６４
assay between LPS and MYC-mNINJ1 (71–110). The expression of 
transfected mNINJ1 constructs was detected by immunoblot analysis 
with MYC antibody (A and B, lower). Bindings between LPS and 
truncated Ninjurin1 were tested (A and B, upper). 
 ６５
A schematic diagram of MYC-tagged truncated mNINJ1 constructs is 
presented. Binding of LPS is denoted as +, and non-binding of LPS is 
denoted as –. 
Figure 20. A schematic diagram of MYC-tagged truncated
mNINJ1 constructs. 
 ６６
8. Investigation on the role of direct binding between Ninjurin1 and 
LPS. 
 
Next, this study investigated the physiological basis of 
Ninjurin1 and LPS binding in the macrophage functions. First, 
endocytosis activity of macrophage was examined. To investigate the 
LPS endocytosis, LPS-FITC was treated to primary macrophage from 
WT and Ninjurin1 KO mouse. After incubation and washing, 
endocytosed LPS-FITC was observed by microscope (Figure 21). 
However, counting endocytosed LSP-FITC in the macrophage showed 
no difference between WT and Ninjurin1 KO primary macrophages 
(Figure 22). Second, Phagocytosis activity of macrophage was studied. 
Phagosomes were observed using pH-sensitive dye labelled E. coli 
particles (pHrodo) (Figure 23). The quantification of phagosomes by 
measuring fluorescence revealed that phagocytosis activity was not 
affected by Ninjurin1 (Figure 24). 
Lastly, LPS-mediated inflammatory response of macrophage 
was investigated. Notably, LPS induced Ninjurin1 expression in 
Raw264.7 macrophages, consistent with the previous report (Jennewein, 
Sowa et al. 2015). To elucidate the role of Ninjurin1 in the LPS-
 ６７
mediated inflammatory response, this study silenced Ninjurin1 
expression with specific or negative control siRNAs (siNinj1 and 
siControl, respectively) in Raw264.7 cells, and subsequently, analysed 
the production of two well-known macrophage activation markers, NO 
and TNFα. Interestingly, the induction of NOS2 protein expression by 
LPS treatment was inhibited in cells transfected siNinj1 (Figure 25A), 
as was NO release (Figure 25B). Similarly, TNFα secretion induced by 
LPS treatment was markedly inhibited in Ninjurin1-knockdown 
Raw264.7 cells (Figure 25C). These results suggested that the LPS-
induced inflammatory response was significantly inhibited by 
Ninjurin1-knockdown, likely due to the decrease of direct interaction 
between Ninjurin1 and LPS. 
 ６８
LPS-FITC (1 μg/ml or 10 μg/ml) was treated to bone marrow-derived 
macrophage. After 24 h incubation, endocytosed LPS-FITC was 
observed by microscope. Scale bar = 10 μm. 
Figure 21. LPS endocytosis assay of primary macrophage. 
 ６９
LPS-FITC (10 μg/ml) was treated to WT (blue line) and Ninjurin1 KO 
(red line) bone marrow-derived macrophage. After 24 h incubation, 
endocytosed LPS-FITC was measured by flow cytometry. Un-treated 
WT (black line) bone marrow-derived macrophage was used for control.  
Figure 22. Comparison of LPS-FITC endocytosis in WT and
Ninjurin1 KO primary macrophages using flow cytometer. 
 ７０
Bone marrow-derived macrophage from WT and Ninjurin1 KO mice 
was treated with pHrodo, pH-sensitive dye labelled E. coli particle. 
After incubating for the indicated time, phagocytosed E. coli particles 
Figure 23. Phagocytosis assay in WT and Ninjurin1 KO primary
macrophages. 
 ７１
were observed by microscope.
 ７２
Fluorescence of phagocytosed E. coil particle was measure by 
microplate reader at 590 nm. The data are mean ± SD. NS, with no 
significance. 
Figure 24. Comparison of phagocytosis in WT and Ninjurin1 KO
primary macrophages. 
 ７３
The expression of Ninjurin1 was downregulated by transfecting 
Ninjurin1 targeted siRNA (siNinj1) or negative control siRNA 
(siControl) in Raw264.7 cells. After 24 h incubation, media was 
Figure 25. Effect of Ninjurin1 downregulation on LPS-induced
Raw264.7 macrophage cell inflammation. 
 ７４
changed with or without 1 μg/ml of LPS. The cell and conditioned 
media at 24 h were collected after LPS stimulation. (A) Protein lysates 
were analysed by immunoblot analysis with Ninj1 Ab139–152, NOS2, and 
GAPDH antibodies. (B) NO release was determined using Griess 
reagent. The concentration of nitrite was calculated from sodium nitrite 
standard curve. (C) TNFα secretion was measured by ELISA assay. 100 
μl of conditioned media was applied to the assay. The data are mean ± 
SD. **, p < 0.01; ***, p < 0.001. 
 ７５
9. Effect of 2-MCA on cell viability and inflammation in Raw264.7 
cells and primary macrophages. 
 
Prior to investigating anti-inflammatory effect of 2-MCA, 
cytotoxicity of 2-MCA was evaluated. Raw264.7 cells and primary 
macrophages were cultured in 96 well plate, and treated 2-MCA at 1.56, 
3.13, 6.25, 12.5, 25, 50, and 100 μM for 24 h. Under these conditions, 
2-MCA did not affect cell viability (Figure 26). 
To evaluate the anti-inflammatory effects of 2-MCA, NO and 
TNFα secretion were measured. These two molecules are well known 
inflammatory markers induced by LPS in macrophages. Raw264.7 cells 
and primary macrophages were pre-treated 2-MCA for 4 h at 3.13, 6.25, 
12.5, 25, 50, and 100 μM. And then simulated by LPS (1 μg/ml) for 24 
h. As a result, Raw264.7 cells and primary macrophages markedly 
increased NO and TNFα secretion by LPS; however the pre-treatment 
of 2-MCA inhibited NO and TNFα secretion from 25 μM to 100 μM 
(Figure 27). 
 ７６
Raw264.7 cells (A) and mouse primary macrophages (B) were culture 
in the presence of various concentrations of 2-MCA for 24 h. After the 
viability was assessed by MTS assay. The data are mean ± SD. 
Figure 26. Cell viability of 2-MCA treated Raw264.7 cells and
primary macrophages. 
 ７７
Raw264.7 cells (A) and primary macrophages (B) were pre-treated 4 h 
with 2-MCA as the indicated concentration. After the further incubated 
24 h with or without LPS (1 μg/ml), the secretion of TNFα was 
measured by ELISA assay. The secretion of NO was measured by 
Griess reagent. The data are mean ± SD. *, p < 0.05; **, p < 0.01; ***, 
p < 0.001, compared to LPS alone-treated sample. 
Figure 27. Inhibition of NO and TNFα secretion by 2-MCA in
Raw264.7 cells and primary macrophages. 
 ７８
10. Investigation on the regulatory mechanism underlying the anti-
inflammatory effect of 2-MCA. 
 
Next, this study investigated signaling molecules regulated by 
2-MCA. Among the vast inflammatory signaling pathways, MAPK, 
NF-κB, AP1, Nrf2, and ATF3 related pathways were examined. First, 
phosphorylation of p38, p44/42, and JNK MAPKs were detected by 
immunoblot analysis. As shown in Figure 28, phosphorylation statuses 
were changed by LPS stimulation; however the pre-treatment of 2-
MCA did not alter the phosphorylation of p38, p44/42, and JNK 
MAPKs. In addition, molecules involved in NF-κB and AP1 signaling 
were also investigated. Phosphorylation of IKKα and β, degradation of 
IκBα, phosphorylation of p65, and expression of c-JUN and c-FOS 
were examined. As a result, these molecules were not inhibited by 2-
MCA pre-treatment (Figure 29). Furthermore, the transcriptional 
activity of NF-κB was measured using pFPR reporter vector. Raw264.7 
cells stably incorporated a pFPR reporter construct. mCerulean was 
constantly expressed by LTR promoter for indicating the presence of 
construct, and mCherry was expressed when transcription factor binds 
to the TRE (Figure 30). LPS dependent expression of mCherry was 
 ７９
verified by observations using microscope (Figure 31A), and flow 
cytometry (Figure 31B). In the flow cytometry analysis, Raw264.7 
cells stably incorporated pFPR-NF-κB with or without 2-MCA pre-
treatment, and LPS stimulation increased double positive cells; 
however 2-MCA pre-treatment did not reduce double positive cells 
significantly (Figure 32). Moreover, the effect of 2-MCA on Nrf2 and 
ATF3 expression was examined. Nrf2 expression was increased by LPS 
under 2-MCA pre-treatment; and ATF3 expression was increase by LPS 
and enhanced by 2-MCA (Figure 33). 
A nucleus translocation of p65, c-JUN, c-FOS, Nrf2, and ATF3 
transcription factors was observed with fractionation. Among these 
transcription factors only Nrf2 and ATF3 were altered by 2-MCA pre-
treatment (Figure 34). Nrf2 translocation was increased by 2-MCA but 
was not induced by LPS; ATF3 translocation was increased by LPS and 
enhanced by 2-MCA. 
Collectively, molecules involved in MAPK (p38, p44/42, and 
JNK), NF-κB (IKKα/β, IκBα, and p65), and AP1 (c-JUN and c-FOS) 
were not altered by 2-MCA pre-treatment in our experimental 
conditions, but Nrf2 and ATF3 were increased by 2-MCA pre-treatment. 
Therefore, this study examined the Nrf2, ATF3, and HO-1 expression 
 ８０
treated by 2-MCA for 24 h time period (Figure 35). Nrf2 and HO-1 
expression was increased by 2-MCA, and decreased after peak point. 
ATF3 was not induced by 2-MCA treatment only. Additionally, effects 
of 2-MCA pre-treatment on LPS-induced Raw264.7 cells were 
examined. Nrf2 expression was not induced by LPS, and the expression 
of ATF3 was induced by LPS under the pre-treatment of 2-MCA, and 
HO-1 was induced by LPS enhancing with 2-MCA pre-treatment 
(Figure 36A). Moreover, Nrf2, ATF3, and HO-1 expression was 
increased depending on 2-MCA concentration, and enhanced by LPS 
treatment (Figure 36B). 
 ８１
Raw264.7 cells (A) and primary macrophages (pMacrophage, B) were 
pre-treated 4 h with or without 2-MCA (50 μM). After the treatment of 
Figure 28. Effect of 2-MCA on activation of MAPK in Raw264.7
cells and primary macrophages. 
 ８２
LPS (1 μg/ml) for the indicated time, the phosphorylation of p38, 
p44/42, and JNK was assessed. 
 ８３
Raw264.7 cells (A) and primary macrophages (pMacrophge, B) were 
Figure 29. Effect of 2-MCA on activation of NF-κB and AP1
signaling in Raw264.7 cells and primary macrophages. 
 ８４
pre-treated 4 h with or without 2-MCA (50 μM). After the treatment of 
LPS (1 μg/ml) for the indicated time, the phosphorylation of IKKα, 
IKKβ, and p65, degradation of IκBα, and expression of c-JUN and c-
FOS was assessed. 
 
 ８５
The schematic presentation of pFPR. mCerulean is constantly 
expressed by 5′ LTR promoter for indicating the presence of construct 
in cells. mCherry is expressed when transcription factor binds to the 
TRE.




Raw264.7 cells were stably transduced with virus particles from pFPR-
empty or pFPR-NF-κB plasmids. (A) Constantly expressed mCerulean 
and NF-κB dependent expressed mCherry were detected by laser 
scanning microscope. Scale bar = 10 μm. (B) Flow cytometry analysis 
of pFPR-empty or pFPR-NF-κB stable Raw264.7 cells stimulated with 
or without LPS (1 μg/ml). 
Figure 31. Measurement of NF-κB transcriptional activity using
pFPR-NF-κB reporter. 
 ８８
A pFPR-NF-κB stable Raw264.7 cells were pre-treated 4 h with or 
without 2-MCA (50 μM). After the treatment of LPS (1 μg/ml) for 24 h. 
Cells were analysed by flow cytometry detecting mCerulean and 
mCherry expression. 
Figure 32. Effect of 2-MCA on NF-κB transcriptional activity in
LPS-induced Raw264.7 cells. 
 ８９
Raw264.7 cells were pre-treated 4 h with or without 2-MCA (50 μM). 
After the treatment of LPS (1 μg/ml) for the indicated time, the 
expression of Nrf2 and ATF3 was assessed. 
Figure 33. Effect of 2-MCA on expression of Nrf2 and ATF3 in
Raw264.7 cells. 
 ９０
Raw264.7 cells were pre-treated 4 h with or without 2-MCA (50 μM). 
After the treatment of LPS (1 μg/ml) for the indicated time, Cells were 
fractionated into cytosol/membrane and nucleus fractions. The nucleus 
translocation of p65, c-JUN, c-FOS, Nrf2, and ATF3 was assessed. 
Figure 34. Effect of 2-MCA on the nucleus translocation of
transcription factors in Raw264.7 cells. 
 ９１
Raw264.7 cells were treated 2-MCA (50 μM) for the indicated time. 
The expression of Nrf2, ATF3, and HO-1 was detected. 
Figure 35. Effect of 2-MCA on expression of Nrf2, ATF3 and HO-1
in Raw264.7 cells for 24 h. 
 ９２
(A) Raw264.7 cells were stimulated by LPS for the indicated time with 
or without the pre-treatment of 2-MCA (50 μM) for 4 h. (B) Raw264.7 
cells were pre-treated 2-MCA by the indicated concentration for 4 h. 
After the treatment of LPS (1 μg/ml) for 4 h, the expression of Nrf2, 
Figure 36. Effect of 2-MCA on Nrf2, ATF3, HO-1 and NOS2 in
Raw264.7 cells depend on stimulation time and 2-MCA
concentration. 
 ９３




This study identified Ninjurin1 as a novel LPS binding partner 
(Figure 14). To determine the region of Ninjurin1 that conveyed its 
ability to bind LPS, binding assays were performed with Ninjurin1 
mutant proteins. These results showed that LPS bound to Ninjurin1 aa 
81–100, which belongs to the first transmembrane domain (Figure 19). 
Ninjurin1 has two transmembrane domains (aa 72–100 aa and aa 118–
139), and both of the regions are highly hydrophobic. In the binding 
assay using MYC-mNINJ1 (101–152), containing the second 
transmembrane domain, LPS-biotin failed to bind to Ninjurin1 (Figure 
19). Based on this observation, this study proposed that LPS binds 
specifically to aa 81–100 of Ninjurin1. To address whether Ninjurin1-
LPS binding affects cellular function, this study repressed Ninjurin1 
expression with siRNA in Raw264.7 cells. Notably, Ninjurin1 
downregulation inhibited LPS-induced NOS2 enzyme induction, NO 
release, and TNFα secretion in Raw264.7 macrophages (Figure 25), 
suggesting that the direct binding of LPS to Ninjurin1 was required for 
the inflammatory activation of macrophages by LPS (Figure 37). 
 ９５
The binding properties of Ninjurin1 were previously 
investigated in several reports that mainly focused on its homophilic 
binding domain (Ifergan, Kebir et al. 2011, Ahn, Le et al. 2014). In 
addition, a heterophilic interaction with unknown molecules has also 
been suggested based on results that the basal adhesion of Jurkat cells 
was inhibited by the treatment with peptides containing Ninjurin1 
adhesion motif (Araki, Zimonjic et al. 1997). Moreover, Ninjurin1 
over-expression led to the enhanced macrophage adhesion to umbilical 
vein endothelial cells and extracellular matrix proteins—such as 
fibronectin, type I collagen, vitronectin, and type IV collagen (Lee, Ahn 
et al. 2009, Lee, Ahn et al. 2010). This study identified LPS as a novel 
heterophilic binding partner of Ninjurin1. Since the lipid moiety of LPS 
is crucial for its binding with Ninjurin1, it would be worthwhile to 
investigate the interaction between Ninjurin1 and other lipid-containing 
molecules. 
Binding region of LPS-interacting partners would likely be a 
potent therapeutic target for inflammatory diseases. For example, 
synthetic peptides of the HMGB1 LPS-binding region, aa 3–15 or aa 
80–96, inhibit the interaction between LPS to HMGB1 in vitro, and 
also decrease TNFα production in a subclinical endotoxemia mouse 
 ９６
model (Youn, Kwak et al. 2011). Thus, this study also sought to 
determine the region of Ninjurin1 responsible for LPS binding. It is 
already known that Ninjurin1 contains a homophilic binding domain 
(aa 26–37) important for its role in immune cell aggregation and 
macrophage-endothelial cell adhesion. Moreover, the aggregation of 
Ninjurin1-expressing Jurkat cells is completely abolished by the 
treatment with Ninjurin1 aa 26–37 peptide (Araki, Zimonjic et al. 
1997), and the treatment with antibody directed towards this protein 
fragment blocks macrophage adhesion and transmigration to 
endothelial cells (Ahn, Le et al. 2014). Furthermore, LPS-induced Il-6 
and Tnfα transcription is inhibited by treatment with this aa 26–37 
peptide (Jennewein, Sowa et al. 2015); however, according to our result, 
LPS specifically bound aa 81–100 of Ninjurin1, but not the N-terminus 
containing the homophilic binding domain. This result indicates that 
Ninjurin1 harbors a LPS-binding motif separated from its homophilic 
binding domain. Therefore, the identification of the specific LPS 
binding region in Ninjurin1 could be valuable for the precise regulation 
of LPS-induced inflammation, as it would presumably not affect the 
protein’s role in cell adhesion. 
Fine regulation of inflammation is important in various 
 ９７
diseases and physiological homeostasis. To find chemical regulator of 
inflammation, the anti-inflammatory activity of 2-MCA was 
investigated in Raw264.7 macrophage cell line and primary bone 
marrow-derived macrophages. Cytotoxicity was examined in the range 
up to 100 μM of 2-MCA, and the viability of these cells was not 
affected (Figure 26). To evaluate the anti-inflammatory activity, the 
secretion of NO and TNFα was measured in Raw264.7 cells and 
primary macrophages stimulated by LPS. In both macrophage cells, the 
pre-treatment of 2-MCA inhibits the secretion of NO and TNFα (Figure 
27). These results correspond with the previous observation, which is 
performed using Raw264.7 and J774A.1 macrophage cell line 
(Gunawardena, Karunaweera et al. 2015). Indeed, this is first study of 
the anti-inflammatory effect of 2-MCA in primary macrophages. 
To elucidate the underlying mechanism for anti-inflammatory 
activity of 2-MCA, immunoblot analysis was performed against 
inflammatory signaling pathways including MAPK, NF-κB, AP1, Nrf2, 
and ATF3. The phosphorylation status of p38, p44/42, and JNK 
MAPKs was not altered by 2-MCA in this experiment using Raw264.7 
cells (Figure 28). Although NF-κB and AP1 signaling proteins were 
also not altered by 2-MCA in our experimental conditions (Figure 29), 
 ９８
Nrf2 and ATF3 transcription factors were induced by 2-MCA pre-
treatment (Figure 36). This observation may suggest that anti-
inflammatory effect of 2-MCA is mediated by Nrf2 and ATF3 
activation. However, further studies using siRNA specific to Nrf2 or 
Atf3 are required to prove the responsibility of these transcription 
factors. Furthermore, the effect of 2-MCA pre-treatment into the 
Ninjurin1 mediated inflammation needs to be elucidated in a future 
studies. 
Besides macrophages, Ninjurin1 is expressed in various cell 
types, such as endothelial cells, pericytes, fibroblasts, and epithelial 
cells (Lee, Ahn et al. 2010, Cho, Rossi et al. 2013, Matsuki, Kabara et 
al. 2015). Moreover, Ninjurin1 is implicated in several human diseases, 
including carcinogenesis of non-muscle-invasive urothelial bladder 
cancer (Mhawech-Fauceglia, Ali et al. 2009) and hepatocellular 
carcinoma (Kim, Moon et al. 2001). Likewise, LPS also affects various 
cell types and pathological conditions, which are not only restricted to 
immune cells. For example, human endothelial cells treated with LPS 
produce neutrophil chemotactic factor (Strieter, Kunkel et al. 1989), 
whereas LPS stimulation in mouse CT26 colon cancer cells triggers 
NF-κB-DNA binding (Luo, Maeda et al. 2004). 
 ９９
Collectively, the Ninjurin1-LPS interaction would likely affect 
various cellular functions beyond macrophage inflammation. Thus, the 
LPS-binding domain of Ninjurin1 would be an attractive therapeutic 






Figure 37. Ninjurin1 regulates LPS-induced inflammation
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Lipopolysaccharide와의 직접적인 결합에 의한 Ninjurin1의 
대식세포유도 염증반응 증가에 관한 연구 
 
Ninjurin1은 세포막 단백질로 염증상황에서 대식세포 
(macrophage)의 이동과 부착에 관여하고 있다. 최근 Ninjurin1 
발현을 억제한 대식세포에서 lipopolysaccharide (LPS)에 의해 
유도된 염증반응이 약화된다는 연구결과가 보고되었다. 그러나 
Ninjurin1이 LPS에 의해 유도된 염증반응을 조절하는 정확한 
기전은 잘 알려지지 않았다. 본 연구에서는 Ninjurin1과 LPS 
사이의 상호작용에 의해 LPS에 의한 염증반응이 조절 된다는 
것을 발견하였다. 인간 또는 마우스 Ninjurin1 단백질을 과발현 
시킨 HEK293T 세포의 용해물 (lysate)과 바이오틴을 결합한 
LPS (LPS-biotin)를 이용한 pull-down assay를 통하여 LPS가 
Ninjurin1에 직접적으로 결합함을 보여주었다. 그리고 다양한 
형태로 발현한 Ninjurin1 단백질의 일부분을 이용한 결합 시험 
(binding assay)에서 Ninjurin1의 81–100 아미노산 부분이 LPS 
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결합에 필요하다는 것을 밝혀냈다. 여기에 더하여 마우스 
대식세포주인 Raw264.7 세포주에서 Ninj1 siRNA를 이용하여 
Ninjurin1 발현을 억제하면 LPS에 의해 증가되었던 일산화질소 
(nitric oxide, NO)와 tumor necrosis factor-alpha (TNFα)의 분비가 
감소되었다. 이상의 결과를 종합해보면, Ninjurin1은 LPS와의 
직접적인 결합을 통하여 LPS에 의해 유도된 염증반응을 조절 
한다는 것을 알 수 있다. 이러한 발견을 통하여 패혈증이나 
염증에 의한 암화과정 같은 염증성 질환의 치료에 Ninjurin1이 
새로운 치료표적이 될 수 있을 것으로 기대된다. 
 
 
Keywords : ninjurin1; lipopolysaccharide; lipopolysaccharide 
binding; inflammation; macrophage 
 
